STOCK TITAN

Clover Health (NASDAQ: CLOV) officer who sold 474K shares plans more

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Clover Health Investments, Corp. (symbol CLOV) received a Rule 144 notice from officer Brady Priest covering planned sales of up to 73,516 shares of common stock, with an indicated aggregate market value of $305,113.45, around 08/31/2026. The notice cites 435,441,337 common shares outstanding. It also reports that Priest sold 474,801 shares for an aggregate $2,171,597.33 on 08/14/2026 and 441,601 shares for $2,141,988.87 on 08/07/2026, all as common stock transactions under Rule 144.

Positive

  • None.

Negative

  • None.
Shares to be sold 73,516 shares of common stock Planned Rule 144 sale around 08/31/2026
Aggregate market value of planned sale $305,113.45 For 73,516 CLOV shares covered by the notice
Shares outstanding 435,441,337 shares CLOV common shares outstanding referenced in the notice
Shares sold on 08/14/2026 474,801 shares CLOV common stock sold by Brady Priest in past three months
Aggregate sale price on 08/14/2026 $2,171,597.33 For 474,801 CLOV shares sold
Shares sold on 08/07/2026 441,601 shares CLOV common stock sold by Brady Priest in past three months
Aggregate sale price on 08/07/2026 $2,141,988.87 For 441,601 CLOV shares sold
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock financial
"Common | 07/18/2024 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Aggregate market value financial
"Common | Morgan Stanley Smith Barney LLC ... | 73516 | 305113.45 | 435441337"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Securities To Be Sold financial
"144: Securities To Be Sold"

FAQ

What does the Form 144 filing for CLOV disclose about Brady Priest’s planned stock sale?

The filing states that officer Brady Priest plans to sell up to 73,516 shares of Clover Health Investments, Corp. common stock under Rule 144, with an indicated aggregate market value of $305,113.45, around 08/31/2026.

How many CLOV shares has Brady Priest sold in the past three months?

The notice reports sales of 474,801 CLOV common shares for $2,171,597.33 on 08/14/2026 and 441,601 shares for $2,141,988.87 on 08/07/2026.

What is the aggregate market value of the CLOV shares covered by the new Form 144?

The Form 144 indicates an aggregate market value of approximately $305,113.45 for the 73,516 CLOV common shares covered by the planned sale notice.

How many Clover Health (CLOV) shares are outstanding according to this Form 144?

The Form 144 lists 435,441,337 CLOV common shares as outstanding in connection with the Rule 144 sales information provided.

What type of CLOV securities are involved in Brady Priest’s Form 144 filing?

The filing covers common stock of Clover Health Investments, Corp., identified as restricted stock to be sold under Rule 144 through a broker, Morgan Stanley Smith Barney LLC Executive Financial Services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature